# FDA Inspection 1161579 - Sumitomo Pharma America, Inc. - November 05, 2021

Source: https://www.keypedia.com/records/fda_inspections/sumitomo-pharma-america-inc/a550c2e4-ac2e-4ab6-b54d-b66fbd2c2ba1
Source feed: FDA_Inspections

> FDA Inspection 1161579 for Sumitomo Pharma America, Inc. on November 05, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1161579
- Company Name: Sumitomo Pharma America, Inc.
- Inspection Date: 2021-11-05
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1242239 - 2024-08-02](https://www.keypedia.com/records/fda_inspections/sumitomo-pharma-america-inc/bad800e7-98e0-43a1-8b2c-1a2d920a304d)
- [FDA Inspection 915063 - 2015-01-23](https://www.keypedia.com/records/fda_inspections/sumitomo-pharma-america-inc/d108866d-e164-4636-94bd-c5c66405a7b5)
- [FDA Inspection 843011 - 2013-05-24](https://www.keypedia.com/records/fda_inspections/sumitomo-pharma-america-inc/c12582b5-74d3-4a7d-a421-e9392e6a3fe4)
- [FDA Inspection 759431 - 2011-12-09](https://www.keypedia.com/records/fda_inspections/sumitomo-pharma-america-inc/7c1c1c35-c67a-4bf4-a6af-768c1a312d45)
- [FDA Inspection 723394 - 2011-04-20](https://www.keypedia.com/records/fda_inspections/sumitomo-pharma-america-inc/2e096e5c-101a-49ce-b1ab-5898e247dc73)

Company: https://www.keypedia.com/companies/sumitomo-pharma-america-inc/f5f01b1a-a43a-478e-a89c-f2d7c3003136

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c